Renalytix Plc (RNLX)
NASDAQ: RNLX · IEX Real-Time Price · USD
0.283
-0.012 (-4.17%)
Jul 22, 2024, 11:21 AM EDT - Market open
Renalytix Employees
Renalytix had 102 employees as of June 30, 2022. The number of employees increased by 45 or 78.95% compared to the previous year.
Employees
102
Change (1Y)
45
Growth (1Y)
78.95%
Revenue / Employee
$21,775
Profits / Employee
-$367,510
Market Cap
27.97M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jun 30, 2022 | 102 | 45 | 78.95% |
Jun 30, 2021 | 57 | 49 | 570.59% |
Jun 30, 2020 | 9 | -1 | -8.60% |
Jun 30, 2019 | 9 | - | - |
Related Stocks
Company Name | Employees |
---|---|
ATI Physical Therapy | 6,000 |
Beyond Air | 107 |
Bolt Biotherapeutics | 100 |
SAB Biotherapeutics | 57 |
Palatin Technologies | 34 |
Acasti Pharma | 32 |
Brainstorm Cell Therapeutics | 29 |
RenovoRx | 8 |
RNLX News
- 11 days ago - Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US - GlobeNewsWire
- 24 days ago - Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination - GlobeNewsWire
- 5 weeks ago - Medicare Issues Final Coverage Determination for kidneyintelX.dkd - GlobeNewsWire
- 2 months ago - Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024 - GlobeNewsWire
- 2 months ago - Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15 - GlobeNewsWire
- 3 months ago - Renalytix Announces Financing with Expected Size of up to $4 Million - GlobeNewsWire
- 4 months ago - KidneyIntelX™ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD) - GlobeNewsWire
- 5 months ago - Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024 - GlobeNewsWire